These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29230931)

  • 21. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
    van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
    Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.
    Han J; Yu H; Tu Y; Pang J; Liu F; Bao Y; Yang W; Jia W
    Diabet Med; 2017 Apr; 34(4):490-499. PubMed ID: 27151271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensification of diabetes medication and risk for 30-day readmission.
    Wei NJ; Wexler DJ; Nathan DM; Grant RW
    Diabet Med; 2013 Feb; 30(2):e56-62. PubMed ID: 23126686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between intensification of blood glucose-lowering therapies, health status and quality of life in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    Davis TME; Bruce DG; Curtis BH; Barraclough H; Davis WA
    Diabetes Res Clin Pract; 2018 Aug; 142():294-302. PubMed ID: 29879496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihyperglycaemic treatment patterns, observed glycaemic control and determinants of treatment change among patients with type 2 diabetes in the United Kingdom primary care: a retrospective cohort study.
    Maguire A; Mitchell BD; Ruzafa JC
    BMC Endocr Disord; 2014 Aug; 14():73. PubMed ID: 25163796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
    Manski-Nankervis JA; Furler J; O'Neal D; Ginnivan L; Thuraisingam S; Blackberry I
    Prim Care Diabetes; 2017 Oct; 11(5):474-481. PubMed ID: 28705697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
    Aschner P; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Chantelot JM; Chan JCN
    Diabetologia; 2020 Apr; 63(4):711-721. PubMed ID: 31901950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort study.
    Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Griffin MR
    BMC Endocr Disord; 2016 Jun; 16(1):32. PubMed ID: 27255309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in HbA1c and frequency of measuring HbA1c and adjusting glucose-lowering medications in the 10 years following diagnosis of type 2 diabetes: a population-based study in the UK.
    Lind M; Pivodic A; Cea-Soriano L; Nerman O; Pehrsson NG; Garcia-Rodriguez LA
    Diabetologia; 2014 Aug; 57(8):1586-94. PubMed ID: 24811709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
    Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
    Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
    Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
    Spirk D; Lareida J; Scheidegger K; Diem P
    Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.